How Tetracycline-Exposed Gut Bacterium Affects Immune and Microbial Responses

The human gut hosts microbes that digest food and affect health, though their exact roles in the presence of prescription drugs is unclear. Now, researchers from Princeton University have published a study in ACS Central Science that details how Bacteroides dorei, one of the most prevalent gut bacteria, reacts to tetracycline antibiotics. These reactions release signals that support immune function, curb pathogens, and adjust the gut microbiome structure. 

"We previously showed that exogenous molecules can trigger production of otherwise ‘hidden’ metabolites in marine- and soil-dwelling microbes,” explained senior author Mohammad Seyedsayamdost. “Our goal here was to extend this analysis to human microbiota and examine their responses to FDA-approved drugs.” Physicians prescribe drugs daily for many conditions, but these can alter beneficial microbes alongside targeting harmful ones.

Antibiotics often eliminate pathogens while harming helpful gut bacteria. Pharmaceuticals may also modify bacterial metabolism, shifting the compounds microbes release and influencing health. Seyedsayamdost and colleagues tested B. dorei cultures against hundreds of U.S. Food and Drug Administration (FDA)-approved drugs, including antihistamines, hypertension treatments, anticancer drugs, and antibiotics. They compared secreted compounds from treated and untreated samples.

Low doses of tetracyclines triggered the strongest changes, prompting B. dorei to produce doreamides—newly named in the study—and N-acyladenosines. Both compounds activated human immune cells to release pro-inflammatory cytokines, aiding infection responses. Doreamides specifically spurred antimicrobial peptides that halted growth in various bacteria, including pathogens, without affecting B. dorei itself.

This shows antibiotics have effects beyond direct microbial killing. Low tetracycline levels make B. dorei generate immune-stimulating compounds and antimicrobial peptides, potentially shifting gut microbial balance. These findings set the stage for animal studies to explore possible therapeutic properties of the doreamides.